Antibacterial Drugs - Antifolates Flashcards
Sulphonamindes - Drugs
Sodium Sulfacetamide
Silver Sulfadiazine
Sulfamethoxazole
Sulphonamindes - MOA
Bacteriostatic
Inhibit production of DNA, RNA and protein by acting as folate antagonists
Compete for dihydropteroate synthetase
Decrease dihydropteroic acid
Sulphonamindes - Kinetics
Good GIT absorbtion
Acetylated in liver
pH 2- 7
Sulfamethoxazole - Spectrum
UTIs Respiratory Infxns Sinusitis Pneumonia Bronchitis
Silver Sulfadiazine - Spectrum
Ulcerative colitis
Enteritis and enteric bacteria
IBD
Sulphonamindes - Spectrum
Both gram +ve and -ve
Broad spectrum
Sulphonamindes - Adverse Effects
Rashes Renal failure (low pH - crystalluria) Blood dyscrasias GIT (nausea, vomiting, anorexia) Kernicterus (neonates) Decreased efficacy of COCP
Sulphonamindes - C/I
Neonates and Infants Last trimester of pregancy Porphyria G6DP deficiency Allergy
Sulphonamindes - D/I
Oral anti-coagulants
Sulfonylureas
Phenytoin
Methotrexate (potentiates effects)
Sodium Sulfacetamide - Administration
Topical
Silver Sulfadiazine - Administration
Topical
Sulfamethoxazole - Administration
Oral administration
Trimethoprim - MOA
Bacteriostatic
Inhibits dihydrofolate reductase, preventing formation of tetrahydrofolate
NB: Affinity for bacterial enzyme = 50000 x > than human
Trimethoprim - Kinetics
Half life: 8 - 11 hours
Excreted unaltered by kidneys
Trimethoprim - Spectrum
Broad spectrum
UTIs
RTIs
Chronic Prostatitis
Trimethoprim - Adverse effects
Megoblastic anaemia
Leukopaenia
Granulocytosis
Trimethoprim - Administration
Oral
Co-trimoxazole =
Trimethoprim + Sulfamethoxazole
Co-trimoxazole - MOA
Bacteriostatic
Sequential blockade: Synergistic action of trimethoprim & sulfamethoxazole
Co-trimoxazole - Spectrum
Broader spectrum than sulphas
Severe RTIs - pneumonia etc
Co-trimoxazole - Adverse Effects
Dermatologic hypersensitivity rxns
GIT disturbances (N,V & anorexia)
Haematological disturbances
Co-trimoxazole - C/I
HIV/AIDs patients
Elderly (esp. on diuretics)
Anaemics
Co-trimoxazole - D/I
Digoxin (↑) Thiazides (↑ risk of thrombocytopenia) COCP (↓ efficacy) Phenytoin (inhibits metabolism) Oral anti-diabetic agents (hypoglycaemia) Pyrimethamine (megaloblastic anaemia) Rifampicin (↓ levels = ↑ dose) Warfarin
Co-trimoxazole - Administration
Oral